Surgepays Price To Earning vs. Cash And Equivalents

SURG Stock  USD 1.98  0.06  3.13%   
Based on Surgepays' profitability indicators, Surgepays is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in January. Profitability indicators assess Surgepays' ability to earn profits and add value for shareholders. The Surgepays' current Operating Cash Flow Sales Ratio is estimated to increase to 0.08, while Price To Sales Ratio is projected to decrease to 0.64. At this time, Surgepays' Net Income is most likely to increase significantly in the upcoming years. The Surgepays' current Net Income From Continuing Ops is estimated to increase to about 21.7 M, while Income Tax Expense is forecasted to increase to (2.2 M).
For Surgepays profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Surgepays to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Surgepays utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Surgepays's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Surgepays over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.78)
Earnings Share
(1.18)
Revenue Per Share
6.864
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.02)
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Surgepays Cash And Equivalents vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Surgepays's current stock value. Our valuation model uses many indicators to compare Surgepays value to that of its competitors to determine the firm's financial worth.
Surgepays is currently regarded as top stock in price to earning category among its peers. It also is currently regarded as top stock in cash and equivalents category among its peers creating about  780,969  of Cash And Equivalents per Price To Earning. Comparative valuation analysis is a catch-all technique that is used if you cannot value Surgepays by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Surgepays Cash And Equivalents vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Surgepays

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
11.14 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Surgepays

Cash

 = 

Bank Deposits

+

Liquidities

 = 
8.7 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Surgepays Cash And Equivalents Comparison

Surgepays is currently under evaluation in cash and equivalents category among its peers.

Surgepays Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Surgepays, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Surgepays will eventually generate negative long term returns. The profitability progress is the general direction of Surgepays' change in net profit over the period of time. It can combine multiple indicators of Surgepays, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income18.9 M19.8 M
Income Before Tax18.4 M19.3 M
Total Other Income Expense Net-485.8 K-510.1 K
Net Income20.6 M21.6 M
Income Tax Expense-2.3 M-2.2 M
Net Income From Continuing Ops20.6 M21.7 M
Net Loss-612.7 K-643.3 K
Net Interest Income-596 K-625.8 K
Interest Income1.3 M1.1 M
Non Operating Income Net Other-518.4 K-544.3 K
Change To Netincome-3.3 M-3.1 M
Net Income Per Share 1.45  1.52 
Income Quality 0.50  0.57 
Net Income Per E B T 1.12  0.80 

Surgepays Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Surgepays. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Surgepays position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Surgepays' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Surgepays without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now

   

Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

Use Investing Themes to Complement your Surgepays position

In addition to having Surgepays in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:
Check out World Market Map.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
To fully project Surgepays' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Surgepays at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Surgepays' income statement, its balance sheet, and the statement of cash flows.
Potential Surgepays investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Surgepays investors may work on each financial statement separately, they are all related. The changes in Surgepays's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgepays's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.